LBA24A RANDOMISED PHASE II STUDY OF CEDIRANIB WITH OR...

Annals of Oncology 2014 / 09 Vol. 25; Iss. suppl_4

LBA24A RANDOMISED PHASE II STUDY OF CEDIRANIB WITH OR WITHOUT SRC INHIBITION (SARACATINIB) IN METASTATIC CLEAR CELL RENAL CANCER (RCC) PATIENTS RESISTANT TO VEGF TARGETED THERAPY

Powles, T., Hawkins, R., Ralph, C., Larkin, J., Jones, R.J., Chowdhury, S., Boleti, E., Fife, K., Bahl, A., Crabb, S., Webb, A., Din, O.S., Dunlop, J., Hill, R., Geldart, T., McLaren, D., Nathan, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu438.25
Date:
September, 2014
File:
PDF, 62 KB
2014
Conversion to is in progress
Conversion to is failed